🚀 From scaling biologics to leading a gene therapy revolution. In this #Biotech2050 episode, host Rahul Chaturvedi talks with Curran Simpson, President & CEO of REGENXBIO, about his path from operations to CEO, the evolution of gene therapy, and building strategic partnerships to deliver life-changing treatments for MPS II, Duchenne, and Wet AMD. A must-listen for biotech leaders navigating today’s complex capital and clinical landscapes. 🎧 Tune in now! → https://xmrrwallet.com/cmx.plnkd.in/gv9HMwyg #GeneTherapy #BiotechLeadership #RareDisease #BiotechPodcast #DigitalHealth #InnovationInMedicine #RareDiseaseTreatment #DuchenneAwareness #MPSSyndrome #WetAMD #VentureBiotech #NAVPlatform
